PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 14528063-6 2003 The NAT2 phenotype was evaluated with dapsone as a test substrate using high-pressure liquid chromatography. Dapsone 38-45 N-acetyltransferase 2 Homo sapiens 4-8 7600914-9 1995 The apparent KM of dapsone acetylation by bacterially expressed NAT1 and NAT2 enzymes was 687 and 136 microM, respectively. Dapsone 19-26 N-acetyltransferase 2 Homo sapiens 73-77 31285712-0 2019 Determination of Arylamine N-Acetyltransferase 2 Acetylation Genotype by PCR and Phenotyping Using Dapsone Through High-Pressure Liquid Chromatography Assay: A Gender Wise Study. Dapsone 99-106 N-acetyltransferase 2 Homo sapiens 17-48 31285712-10 2019 Therefore, it is concluded that NAT2 acetylation rate can be used to check in vivo acetylation status with dapsone as probe drug. Dapsone 107-114 N-acetyltransferase 2 Homo sapiens 32-36 31285712-11 2019 It is concluded that NAT2 acetylation rate was unaffected by gender and can be used to check in vivo acetylation status with dapsone as probe drug, which is inexpensive and less time-consuming. Dapsone 125-132 N-acetyltransferase 2 Homo sapiens 21-25 30472588-2 2019 In this study, we used a cocktail of bupropion, losartan and dapsone for in vivo phenotyping of CYP2B6, CYP2C9 and N-acetyltransferase-2 (NAT2) in plasma. Dapsone 61-68 N-acetyltransferase 2 Homo sapiens 138-142 30472588-14 2019 CONCLUSIONS: This study advocates the use of a cocktail of bupropion, losartan and dapsone for in vivo phenotyping of CYP2B6, CYP2C9 and NAT2, which is important in determining therapeutic dose levels of anti-HIV and anti-TB drugs in HIV/AIDS-TB coinfections. Dapsone 83-90 N-acetyltransferase 2 Homo sapiens 137-141 15999287-5 2005 Further investigation revealed a marked decrease of the enzyme activity of N-acetyltransferase 2, which plays an important role in dapsone metabolism. Dapsone 131-138 N-acetyltransferase 2 Homo sapiens 75-96 10589083-3 1999 Dapsone is partly metabolized by the polymorphic N-acetyltransferase 2% and 50% of Caucasian patients show a genetically determined slow acetylator phenotype. Dapsone 0-7 N-acetyltransferase 2 Homo sapiens 49-70 7669073-5 1995 The apparent Km values (at 100 microM acetyl CoA as co-substrate) of the different NAT2 variants for sulphamethazine, dapsone, p-anisidine, 2-aminofluorene, procainamide and isoniazid were determined. Dapsone 118-125 N-acetyltransferase 2 Homo sapiens 83-87 7669073-7 1995 The apparent Km for the structurally related sulphone antibiotic dapsone was 5-fold lower for the slow variant NAT2 7B when compared with the wild-type NAT2 4. Dapsone 65-72 N-acetyltransferase 2 Homo sapiens 111-115 7669073-7 1995 The apparent Km for the structurally related sulphone antibiotic dapsone was 5-fold lower for the slow variant NAT2 7B when compared with the wild-type NAT2 4. Dapsone 65-72 N-acetyltransferase 2 Homo sapiens 152-156 7669073-8 1995 These results indicate that the NAT2 7B specific amino acid substitution, Gly286-Glu, is important in promoting the binding of sulphamethazine and dapsone to the active site. Dapsone 147-154 N-acetyltransferase 2 Homo sapiens 32-36 28322460-0 2017 Dapsone-induced agranulocytosis-possible involvement of low-activity N-acetyltransferase 2. Dapsone 0-7 N-acetyltransferase 2 Homo sapiens 69-90